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The objective of the present investigation was to explore
the potential of nanoemulsion (NE) containing arte-
mether-curcumin combination to accomplish the deliv-
ery of drugs to the brain via olfactory delivery system
for management of cerebral malaria. The components
for curcumin NE (C-NE) and artemether NE (A-NE)
formulations were selected based on saturation solubility
studies and were prepared by aqueous titration techni-
que [1]. The mucoadhesive drug loaded nanoemulsions
were made by adding chitosan (0.50% w/w) and stirred
for 1 h. The nanoemulsions showed average globule size
ranging from 32-70nm with polydispersity index of
0.221-1.000 and zeta potential in range of -12 to -28
mV. The formulations were subjected to thermodynamic
stability tests like Heating-Cooling cycle, Freeze Thaw
cycle and Centrifugation. All those formulations which
passed the tests were subjected for further evaluation like
transmittance, refractive index and electroconductivity
tests. The percent transmittance of the formulations was
>98% and refractive index was in range of 1.3-1.4 indicat-
ing transparent nature of nanoemulsions. Nanoemulsions
exhibited high electroconductivity confirming that they
were oil-in-water type. Transmission electron microscopy
studies confirmed that globules were spherical in shape
and size was in agreement with results obtained from
globule size analysis. The nanoemulsions were evaluated
for cytotoxicity studies using Vero cell lines by MTT
assay. The CTC50 value of C-NE and A-NE was found to
be 1950 meg/ ml and 2000mcg/ml respectively. Hemoly-
tic activity was within the acceptable range revealing low
toxicity risk of nanoemulsion. The ex vivo release studies
of the formulated nanoemulsions were carried out using
sheep nasal mucosa in comparison with drug suspension
in simulated nasal fluid. The results revealed that release
rate was biphasic and faster from drug suspension as
compared to nanoemulsions. It can be concluded that
nanoemulsions were prepared successfully having low
particle size and can be used to deliver curcumin and
artemether intranasally for management of cerebral
malaria. The efficacy of the developed formulations either
alone or in combination was evaluated further for anti-
malarial efficacy in Plasmodium berghei ANKA murine
model of cerebral malaria in comparison with pure drug
suspension administered intranasally and intravenously
and showed promising results.
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